share_log

Goldman Sachs Upgrades MorphoSys to Neutral, Raises Price Target to $9.25

Benzinga ·  Sep 15, 2023 04:11

Goldman Sachs analyst Rajan Sharma upgrades MorphoSys (NASDAQ:MOR) from Sell to Neutral and raises the price target from $3.5 to $9.25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment